ReviewThe Journal of reproduction and development2026
Considerations for recipient male selection in a livestock Surrogate Sire breeding strategy.
Review in The Journal of reproduction and development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surrogate Sires is a novel breeding technology for increasing the rate of genetic gain in food animal production settings through natural mating. As an overarching concept, a surrogate sire is a male possessing testes devoid of germ cells yet capable of harboring spermatogenesis following introduction of donor germline. The utility of this technology relies on recipient males that are not only germline ablated and capable of harboring donor-derived spermatogenesis but also otherwise phenotypically normal and readily produced. Since the advent of spermatogenic stem cell transplantation in mice, many methods have been used to generate surrogate males by either removing germline with cytotoxic treatments or preventing germ cell survival and/or development through gene editing. At present, the use of gene editing to cause germline ablation shows the most promise as the precise inactivation of genes involved in germ cell development allow for testis-specific effects and have been assessed for the ability to harbor spermatogenesis from introduced donor germline. Of particular interest is the knockout of NANOS2 as the consistent germline ablation phenotype and proven production of donor-derived spermatogenesis combined with the fertility of both knockout females and heterozygous males establishes a clear and simple means for the scaling and use of Surrogate Sires in livestock production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.